Tumor-Associated Macrophages in the Immunotherapy of Gynecological Cancers: Mechanisms, Resistance, and Emerging Strategies
International Journal of General Medicine · 2026-11 · Volume 19 · 1-29
DOI: 10.2147/ijgm.s652601 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2026-11. Verfasst von Qianyin Wang und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) are highly plastic and heterogeneous components of the tumor microenvironment (TME) in ovarian, endometrial, and cervical cancers. Their context-dependent states influence angiogenesis, invasion, immune escape, and treatment response. This narrative review examines the mechanisms governing TAM recruitment, polarization, and metabolic adaptation; summarizes tumor-specific evidence and associations with prognosis and immunotherapy response; and evaluates emerging approaches including CSF-1/CSF-1R and TREM1/2 targeting, macrophage reprogramming, gene engineering, and nanomedicine. A focused narrative literature search was used to identify experimental, observational, and clinical studies relevant to TAM biology and immunotherapy in gynecological malignancies (the databases, search dates, language restrictions, and eligibility criteria are detailed in the Introduction). The available evidence is predominantly preclinical or observational. Early clinical studies, including trials of myeloid-targeting antibodies in platinum-resistant ovarian cancer and HER2-directed CAR macrophages in advanced solid tumors, provide initial translational data but do not yet establish clinical efficacy in gynecological cancers. We highlight tumor-specific differences, limitations of the simplified M1/M2 polarization framework, and key barriers to translation, including TAM heterogeneity, context-dependent macrophage functions, safety, and the need for biomarker-guided patient selection.
Zitieren
APA
Wang, Q., Wang, F., Xiao, H., Min, Y., Liu, Y., & Wang, L. (2026). Tumor-Associated Macrophages in the Immunotherapy of Gynecological Cancers: Mechanisms, Resistance, and Emerging Strategies. International Journal of General Medicine, Volume 19, 1-29. https://doi.org/10.2147/ijgm.s652601
Vancouver
Wang Q, Wang F, Xiao H, Min Y, Liu Y, Wang L. Tumor-Associated Macrophages in the Immunotherapy of Gynecological Cancers: Mechanisms, Resistance, and Emerging Strategies. International Journal of General Medicine. 2026;Volume 19:1-29. doi:10.2147/ijgm.s652601
BibTeX
@article{Wang2026,
author = {Wang, Qianyin and Wang, Fei and Xiao, Han and Min, Yunyun and Liu, Yuqin and Wang, Liehong},
title = {Tumor-Associated Macrophages in the Immunotherapy of Gynecological Cancers: Mechanisms, Resistance, and Emerging Strategies},
journal = {International Journal of General Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--29},
doi = {10.2147/ijgm.s652601}
}
EUVIMED